Vanguard Pharma announces specialty sales contract to launch in Q4 2011
August 15, 2011 01:52 PM
Vanguard Pharma is pleased to announce that it has been awarded a new 16-month specialty sales contract to begin in Q4 of 2011. The client has a successful, multi-year relationship with Vanguard Pharma, and this latest project "underscores the flexibility and value that Vanguard Pharma brings to the pharmaceutical industry," according to Kevin Danylchuk, President and General Manager of Vanguard Pharma. "The specialty sales arena is nicely coming of age as more and more industry firms recognize the benefits of using a CSO in specialty markets as well as primary care markets. We are pleased to now say that we have partnered in both these capacities with this long-standing client."
To request more information about Vanguard Pharma, please visit out Contact Us page.